Home NDC 63323-322-01 NDC 63323-322-01 - Imipenem and Cilastatin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63323-322
Requested NDC 63323-322-01
Package NDCs from labels 63323-322-21, 63323-322-93, 63323-322-41, 63323-322-94, 63323-322-01, 63323-322-25
Manufacturer Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd
Effective date 2022-10-11
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-322-01 Imipenem and Cilastatin 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, FOR SOLUTION 20 12 63323-322-25 Imipenem and Cilastatin 25 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 25 12 63323-322-41 Imipenem and Cilastatin 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, FOR SOLUTION 20 7 63323-322-94 Imipenem and Cilastatin 25 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 25 7 63323-322-21 Imipenem and Cilastatin 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, FOR SOLUTION 20 5 63323-322-93 Imipenem and Cilastatin 25 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 25 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-322 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 12 Current NDC, Legacy NDC, 2 package rows 20221020_6ab0ca9e-9a79-4cab-9f09-470eda06952e.zip 63323-322 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 7 Current NDC, Legacy NDC, 2 package rows 20221027_0a1dd9b9-ada1-4bff-9dcb-18961254e9e8.zip 63323-322 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 5 Current NDC, Legacy NDC, 2 package rows 20221103_ce771566-c4f2-447e-944a-6b908925c90b.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CILASTATIN SODIUM ACTIVE INGREDIENT 5428WXZ74M IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 4 IMIPENEM ACTIVE INGREDIENT 71OTZ9ZE0A IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 4 CILASTATIN ACTIVE MOIETY 141A6AMN38 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 4 IMIPENEM ANHYDROUS ACTIVE MOIETY Q20IM7HE75 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 4 CILASTATIN SODIUM ACTIVE INGREDIENT 5428WXZ74M IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 IMIPENEM ACTIVE INGREDIENT 71OTZ9ZE0A IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 CILASTATIN ACTIVE MOIETY 141A6AMN38 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 IMIPENEM ANHYDROUS ACTIVE MOIETY Q20IM7HE75 IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 11 of 11 · 212 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES Novel Laboratories, Inc. 29d821ff-389c-41fb-8a27-89bd3f022b82 2023-02-08 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO Omeprazole, Sodium bicarbonate OMEPRAZOLE, SODIUM BICARBONATE Guardian Drug Company e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 2022-11-08 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO Imipenem and Cilastatin IMIPENEM AND CILASTATIN SODIUM Fresenius Kabi USA, LLC ce771566-c4f2-447e-944a-6b908925c90b 2022-10-11 Warnings, Adverse reactions Exact identifier application number: ANDA090577 ndc (package): 63323-322-93 ndc (package): 63323-349-21 ndc (package): 63323-349-93 ndc (package): 63323-322-21 ndc (product): 63323-349 ndc (product): 63323-322 rxcui: 1726204 spl id: 68d30458-8cd9-4fbe-9215-f36dec6c733b spl set id: ce771566-c4f2-447e-944a-6b908925c90b unii: 71OTZ9ZE0A unii: 5428WXZ74M Imipenem and Cilastatin IMIPENEM AND CILASTATIN SODIUM Fresenius Kabi USA, LLC 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 2022-10-10 Warnings, Adverse reactions Exact identifier application number: ANDA090577 ndc (package): 63323-349-94 ndc (package): 63323-349-41 ndc (package): 63323-322-94 ndc (package): 63323-322-41 ndc (product): 63323-349 ndc (product): 63323-322 rxcui: 1726204 spl id: fb64108d-9be7-4eef-9395-74c782e3a3c0 spl set id: 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 unii: 71OTZ9ZE0A unii: 5428WXZ74M Imipenem and Cilastatin IMIPENEM AND CILASTATIN SODIUM Fresenius Kabi USA, LLC 6ab0ca9e-9a79-4cab-9f09-470eda06952e 2022-10-06 Warnings, Adverse reactions Exact identifier application number: ANDA090577 ndc (package): 63323-322-01 ndc (package): 63323-349-25 ndc (package): 63323-322-25 ndc (package): 63323-349-01 ndc (product): 63323-349 ndc (product): 63323-322 ndc11 (package): 63323032201 rxcui: 1726204 spl id: 2bb9b6ad-8e8d-4667-b108-b57a8c16318f spl set id: 6ab0ca9e-9a79-4cab-9f09-470eda06952e unii: 71OTZ9ZE0A unii: 5428WXZ74M Sodium Bicarbonate SODIUM BICARBONATE International Medication Systems, Limited 77698221-a01d-4568-a7bc-d3d4e982875d 2021-12-15 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO 8.4% SODIUM BICARBONATE 8.4% SODIUM BICARBONATE HF Acquisition Co. LLC, DBA HealthFirst 74d8bb7a-9e7a-105f-e053-2a91aa0aec92 2021-05-03 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO SODIUM BICARBONATE SODIUM BICARBONATE Medical Purchasing Solutions, LLC bfc9c321-665c-ca97-e053-2995a90a7954 2021-04-12 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO SODIUM BICARBONATE SODIUM BICARBONATE Aphena Pharma Solutions - Tennessee, LLC 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc 2017-12-13 Warnings Exact identifier unii: 8MDF5V39QO Sodium Bicarbonate Antacid SODIUM BICARBONATE Richmond Pharmaceuticals, Inc. e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce 2017-11-01 Warnings Exact identifier unii: 8MDF5V39QO SODIUM BICARBONATE SODIUM BICARBONATE Richmond Pharmaceuticals, Inc. fa10d93d-b3ed-4675-a117-f573d9e72bca 2017-10-30 Warnings Exact identifier unii: 8MDF5V39QO Sodium Bicarbonate SODIUM BICARBONATE Exela Pharma Sciences, LLC e9698a4f-1a95-4f28-a945-e8009d1d6dd4 2017-09-27 Warnings, Adverse reactions Exact identifier unii: 8MDF5V39QO
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.